Skip to main content
Fig. 1 | Experimental Hematology & Oncology

Fig. 1

From: 19-Hydroxybufalin inhibits non-small cell lung cancer cell proliferation and promotes cell apoptosis via the Wnt/β-catenin pathway

Fig. 1

19-HB inhibited proliferation and changed cell morphology in NSCLC cells. a Chemical structure of 19-HB. b Light scope showed cell morphology changes in NSCLC cells treated with 19-HB for 24 h. c Cell viability was determined by a CCK-8 assay at 24, 48, and 72 h after treatment. d Cell proliferation determined by colony formation assay and colony formation numbers were calculated after 14 days of culture in 24-h 19-HB-treated cell lines. The data are presented as the mean ± SD of three parallel tests (*P < 0.05 vs. control, **P < 0.01 vs. control)

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us